Search
for
Sort by
Research 481–510 of 1000+
- Concomitant immobilization of androgen receptors and 5α- reductase in androgenic alopecia
- Analysis of androgen receptor expression and activity in the mouse brain
- Androgen excess: a hallmark of polycystic ovary syndrome
- Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase
- Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors
- Dermatology of androgen-related disorders
- How should postmenopausal androgen excess be evaluated?
- Androgen receptor gene polymorphism and polycystic ovary syndrome
- Effects of Short-Term Finasteride on Apoptotic Factors and Androgen Receptors in Prostate Cancer Cells
- Graham Little-Piccardi-Lassueur syndrome associated with androgen insensitivity syndrome (testicular feminization)
- Androgens in Women – Critical Evaluation of the Methods for Their Determination in Diagnostics of Endocrine Disorders
- Androgen profile in Chinese women with polycystic ovary syndrome in their reproductive years
- Bicalutamide does not raise transaminases in comparison to alternative anti-androgen regimens among transfeminine adolescents and young adults: a retrospective cohort study
- Androgen deprivation therapy and hormonal status in men with COVID-19
- In response to the letter to the editor by Soha Ghanian et al. re our publication “Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males”
- Salivary Inflammatory Markers and Free Androgen Index in Women with Polycystic Ovary Syndrome: A Case-Control Study
- Hair Loss and Androgen’s Role in the Era of COVID-19
- 174 Changes in urine androgen and PG levels during finasteride treatment
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- PLASMA C19 STEROID SULPHATE LEVELS AND INDICES OF ANDROGEN BIOAVAILABILITY IN FEMALE PATTERN ANDROGENIC ALOPECIA
- 46,XY DSD due to impaired androgen production
- A variant of the glucocorticoid receptor gene is not associated with adrenal androgen excess in women with polycystic ovary syndrome
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men
- Hepatotoxicity Associated with Anabolic Androgenic Steroids and Selective Androgen Receptor Modulators: A Literature Review
- 864 Catalytic-dependent and -independent activities of Polycomb repressive complex 1 differentially regulate skin stem cell specification
- Free androgen index (FAI)’s relations with oxidative stress and insulin resistance in polycystic ovary syndrome
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Insights into the context-dependent immunological roles of the CXCL12–CXCR4 axis in alopecia
- Reversal of andro-genetic alopecia in a male. A spironolactone effect?